Haemostatix's Acquisition

Haemostatix was acquired by Ergomed on May 04, 2016.

Haemostatix is a biopharmaceutical company developing first-in-class therapies for the treatment of bleeding or 'haemostasis'. The company has pioneered a new approach to haemostasis based on targetin…

Articles about Haemostatix's Acquisition: